REDHILL BIOPHARMA LTD. Adjustments For Increase Decrease In Derivative Financial Liabilities
REDHILL BIOPHARMA LTD. (RDHL) reported Adjustments For Increase Decrease In Derivative Financial Liabilities of -$5.57 million for the 12-month period ending 2023-12-31, per its 20-F filed 2024-04-08.
Discontinued › Notes › Derivative Instruments and Hedging Activities
ifrs-full:AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities · last filed 2024-04-08
| Period end | Adjustments For Increase Decrease In Derivative Financial Liabilities 6 month | Adjustments For Increase Decrease In Derivative Financial Liabilities 12 month |
|---|---|---|
| 2023-12-31 | -$5.57M 20-F · filed 2024-04-08 | |
| 2023-06-30 | $8.07M 6-K · filed 2023-08-17 | |
| 2022-12-31 | $13.42M 20-F · filed 2024-04-08 | |
| 2022-06-30 | $1.98M 6-K · filed 2023-08-17 |